Ravi Misra
Stock Analyst at Truist Financial
(0.49)
# 4,131
Out of 4,504 analysts
38
Total ratings
35%
Success rate
-10.7%
Average return
Main Sectors:
Stocks Rated by Ravi Misra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORGO Organogenesis Holdings | Initiated Coverage: Hold | $3 | $2.40 | +25.00% | 1 | May 28, 2026 | |
| TFX Teleflex | Reiterated: Hold | $143 | $135.73 | +5.36% | 1 | May 11, 2026 | |
| IART Integra LifeSciences Holdings | Maintained: Hold | $14 | $18.79 | -25.49% | 1 | May 6, 2026 | |
| KIDS OrthoPediatrics | Reiterated: Hold | $17 | $20.33 | -16.38% | 1 | May 1, 2026 | |
| ALGN Align Technology | Rated: Hold | n/a | $179.45 | n/a | 4 | Dec 13, 2021 | |
| DXCM DexCom | Rated: Hold | n/a | $74.96 | n/a | 2 | Dec 13, 2021 | |
| PODD Insulet | Rated: Hold | n/a | $161.28 | n/a | 3 | Dec 13, 2021 | |
| TNDM Tandem Diabetes Care | Rated: Hold | n/a | $15.41 | n/a | 2 | Dec 13, 2021 | |
| AVNS Avanos Medical | Rated: Hold | n/a | $24.93 | n/a | 2 | Dec 13, 2021 | |
| GKOS Glaukos | Rated: Hold | n/a | $152.72 | n/a | 2 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.28 | n/a | 7 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $51.76 | n/a | 5 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.05 | n/a | 2 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.91 | n/a | 4 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $283 | $406.78 | n/a | 1 | Apr 19, 2017 |
Organogenesis Holdings
May 28, 2026
Initiated Coverage: Hold
Price Target: $3
Current: $2.40
Upside: +25.00%
Teleflex
May 11, 2026
Reiterated: Hold
Price Target: $143
Current: $135.73
Upside: +5.36%
Integra LifeSciences Holdings
May 6, 2026
Maintained: Hold
Price Target: $14
Current: $18.79
Upside: -25.49%
OrthoPediatrics
May 1, 2026
Reiterated: Hold
Price Target: $17
Current: $20.33
Upside: -16.38%
Align Technology
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $179.45
Upside: n/a
DexCom
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $74.96
Upside: n/a
Insulet
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $161.28
Upside: n/a
Tandem Diabetes Care
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $15.41
Upside: n/a
Avanos Medical
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $24.93
Upside: n/a
Glaukos
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $152.72
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $9.28
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $51.76
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $1.05
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $9.91
Upside: n/a
Apr 19, 2017
Reiterated: Buy
Price Target: $283
Current: $406.78
Upside: n/a